LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $28,633,000 | -7.9% | 3,843,312 | -14.1% | 0.00% | 0.0% |
Q4 2016 | $31,096,000 | -32.0% | 4,474,312 | -19.5% | 0.00% | -33.3% |
Q3 2016 | $45,741,000 | +0.0% | 5,557,812 | -1.5% | 0.01% | 0.0% |
Q2 2016 | $45,725,000 | +62.4% | 5,645,114 | +1.9% | 0.01% | +50.0% |
Q1 2016 | $28,155,000 | -36.2% | 5,542,228 | -3.0% | 0.00% | -33.3% |
Q4 2015 | $44,126,000 | +32.1% | 5,715,828 | -1.4% | 0.01% | +20.0% |
Q3 2015 | $33,393,000 | -37.2% | 5,797,328 | 0.0% | 0.01% | -28.6% |
Q2 2015 | $53,161,000 | -23.6% | 5,797,328 | +0.9% | 0.01% | -22.2% |
Q1 2015 | $69,600,000 | – | 5,747,328 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 3,180,913 | $18,322,000 | 4.76% |
ACUTA CAPITAL PARTNERS, LLC | 1,314,959 | $7,574,000 | 4.38% |
Perceptive Advisors | 5,910,912 | $34,046,000 | 1.36% |
P.A.W. CAPITAL CORP | 200,000 | $1,152,000 | 1.32% |
Ghost Tree Capital, LLC | 300,000 | $1,728,000 | 0.78% |
Broadfin Capital, LLC | 2,105,519 | $12,128,000 | 0.68% |
Rhenman & Partners Asset Management AB | 683,108 | $3,935,000 | 0.63% |
Trellus Management Company, LLC | 60,539 | $349,000 | 0.51% |
Cormorant Asset Management, LP | 499,815 | $2,879,000 | 0.46% |
QVT Financial LP | 1,433,700 | $8,258,000 | 0.28% |